Pharma
sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

See Latest Articles
(Click the title below to leave the MDLinx Network and go to the Journal's Website)

MabThera approved in the EU for patients with chronic lymphocytic leukaemia
Roche, 03/02/09

Roche announced that the European Commission has approved MabThera in combination with chemotherapy for use in patients with previously-untreated chronic lymphocytic leukaemia, the most common type of leukaemia to affect adults. The approval is based on compelling results from the pivotal phase III study CLL8.

Today in Drug/Product Approvals...keeping you current

Abbott Seeks FDA Approval of New Dosage Strengths of SIMCOR
Abbott, 12/10/09

Recombinant Human Erythropoietin, Epogin Injection Application for Approval of Additional Indication of Chemotherapy-Induced Anemia
Chugai Pharmaceutical Co., 12/08/09

Synthon announces European approvals for Raloxifene
Synthon, 12/08/09

 See all of Drug/Product Approvals

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address